Different pathologic responses to neoadjuvant anti-PD-1 in primary squamous lung cancer and regional lymph nodes

Neoadjuvant immunotherapy provides a unique opportunity for understanding therapeutic responses. We analyzed pathologic responses in surgical specimens obtained from 31 squamous non-small cell lung cancer (NSCLC) patients receiving neoadjuvant anti-PD-1 treatment. Fifteen (48.4%) patients achieved p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:NPJ Precis Oncol
Autors principals: Ling, Yun, Li, Ning, Li, Lin, Guo, Changyuan, Wei, Jiacong, Yuan, Pei, Tan, Fengwei, Tao, Xiuli, Wang, Shuhang, Wang, Zhijie, Wu, Ning, Wang, Jie, Ying, Jianming, Gao, Shugeng, He, Jie
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7708412/
https://ncbi.nlm.nih.gov/pubmed/33299121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-020-00135-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars